BRUKINSA ZANUBRUTINIB
Live / Registered — Registered (as of 19 Jan 2021)
What this means for you
Registered since 19 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88337582
- Registration number
- 6252000
- Mark type
- Design + words
- Filed
- 13 Mar 2019
- Published for opposition
- 31 Dec 2019
- Registered
- 19 Jan 2021
- Attorney of record
- Kristen S. Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals comprising zanubrutinib for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
Owner
- BEONE MEDICINES I GMBH, BASEL, CH
- BG NC 1, LTD., GRAND CAYMAN, KY
- BEONE MEDICINES LTD., BASEL, KY
- BeiGene, Ltd., San Mateo, CA, KY
- BeiGene, Ltd., Grand Cayman, KY
- BeiGene, Ltd., Grand Cayman, KY
Prosecution history
- 19 Jan 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Oct 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 29 Oct 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Jul 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Jul 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 24 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Mar 2021 — CORRECTION UNDER SECTION 7 - PROCESSED
- 02 Mar 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL